Prof Joseph Doyle was appointed President and Chair of Hepatitis Australia in March 2024.  Joe brings a wealth of knowledge, governance and leadership experience to this role.

Joe is a clinical researcher, dual trained in infectious diseases and public health medicine, in particular hepatitis and HIV epidemiology, treatment and translational work leading to disease elimination.  He is currently Professor in Infectious Diseases at Monash University, and is jointly appointed at Burnet Institute as Deputy Director of Disease Elimination Program and head of Infectious Diseases Clinical Research. Joe has experience in translating important discoveries into national and global clinical guidelines and has been appointed by state and federal governments to statutory bodies to shape guidelines, regulations and treatment access.

Frank joined the Board in August 2023 becoming Vice President in November 2023.  Frank also chairs the Governance Committee and is a member of the Finance & Risk Committee.

Frank is an experienced Board Director with a focus on serving for-purpose organisations with a mission aimed at promoting the wellbeing of disadvantaged and vulnerable people and communities. He is a graduate of the Australian Institute of Company Directors and a member of the Institute of Community Directors Australia. 

He is a former Director and President of LiverWELL (incorporating Hepatitis Victoria). He is currently a Director and Board Chair of Timboon and District Healthcare Service.

Frank has worked in direct care, policy and senior management positions across a range of health and human services and programs, including child protection, adoption and permanent care services, family and adolescent welfare, disability, housing and health and aged care. 

Frank served as the Acting President of Hepatitis Australia between November 2023 – April 2024.

Frank has lived experience with Hepatitis C and is the grateful recipient of a donor liver.

Cameron Brown rejoined the Board of Hepatitis Australia in May 2024, having previously served as Treasurer, Secretary, and Chair of the Finance and Risk Committee from 2018 to 2022.

He is the Chief Executive Officer of the Tasmanian Council on AIDS, Hepatitis and Related Diseases Inc. (TasCAHRD), a Member of the Australian Institute of Company Directors, and holds a Graduate Certificate in Business from QUT.

Cameron brings extensive executive experience across both public and private sectors, including leadership roles within the dealer networks of General Motors and Hyundai Motor Company. He has also held senior positions with Medicare Australia and the Department of Human Services, where he led major projects and change initiatives that delivered significant public value and improved customer outcomes.

He contributes actively to health policy and advocacy through his involvement in multiple Tasmanian Government reference groups focused on LGBTIQA+ health, BBV/STI, and sexual and reproductive health. Cameron is also a Member of the Tasmanian Health Senate.

Adjunct Associate Professor Anna Hawkes joined the Hepatitis Australia Board and Governance Committee in June 2024. Anna has Australian Institute of Company Directors training in not-for-profit governance and has served on/chaired numerous Boards and Committees. Anna holds a PhD and Masters degree in Public Health.

Anna is the Chief Executive Officer of Hepatitis Queensland and has a wealth of experience in public health policy, practice, and research. Before joining Hepatitis Queensland, Anna was the Engagement and Strategy Lead in the Blood Borne Virus and Sexually Transmissible Infections Unit at Queensland Health leading the Queensland Sexual Health Ministerial Advisory Committee. For the past 30 years, she’s worked in executive leadership roles for Government, Universities, and not-for-profit community organisations including the Cancer Council Queensland and Heart Foundation.

Anna’s passionate about improving health outcomes with a focus on equity and inclusion for marginalised groups.

Steven has been a Board Director of Hepatitis Australia since October 2019 and was Treasurer until November 2022.

Steven is the CEO of Hepatitis NSW and has extensive executive experience spanning over a decade that covers executive, government, bureaucracy and member-based, not for profit, charity sectors. Steven has almost 15 years’ experience as a Board Director in Australia and Ireland. Steven is a Graduate of the Australian Institute of Company Directors and was a member of the Institute of Directors in Ireland from 2016 to 2019.

Kerry has been a Board Director of Hepatitis Australia for various periods since 1999. Kerry is a member of the Finance and Risk Committee.

Kerry is the CEO of Hepatitis SA. Kerry was the Manager at the then Hepatitis C Council of South Australia from 1999 for three and half years prior to commencing as National Strategic Development Officer at what was then the Australian Hepatitis Council (now Hepatitis Australia) for a period of two and a half years. Kerry then returned to Hepatitis SA in 2005. Kerry is a member of the South Australian Sexually Transmissible Infections and Blood-Borne Viruses Advisory Committee.

Michael has been a Board Director of Hepatitis Australia since January 2024 and is a member of the Governance Committee. He is also a member of the Research and Clinical Advisory Group.

Michael is a Public Health Physician with international experience in prisoner health.

In June 2014 he was recognised for meritorious service with Membership of the Order of Australia (AM) - “For significant service to medicine in the field of public health as a clinician, academic and educator.”

He remains on the national register of experts maintained by the Australian Commonwealth Ombudsman’s Office, as a specialist in healthcare in detention.

Professor Jane Davies is the Northern Territory representative on the board, joining in November 2024. As a respected Infectious Diseases clinician researcher and lead of the Hep B PAST program, Prof Davies brings a proven ability to build and lead effective partnerships as well as expert knowledge in viral hepatitis and world class clinical and research experience.

Jane is a triple accredited specialist physician in Infectious Diseases, Tropical and General Medicine trained in the UK prior to moving to the Northern Territory in 2010 where she then completed her PhD with Menzies School of Health research in viral hepatitis and public health. She has worked with and for communities in England, Tanzania, Malawi, England and the Northern Territory.

She leads the successful Hep B PAST program which has closed the gap for Aboriginal and Torres Strait Islander people living with Chronic hepatitis B being engaged in care across the Northern Territory. In addition she is involved in regional, national and International advisory bodies around viral hepatitis guidelines, research and clinical strategies.

Rebecca joined the Hepatitis Australia Board in March 2025 when she commenced as Chief Executive Officer of HepatitisWA.

She brings over 20 years’ experience in the for-purpose health sector in both executive and board director roles, including positions at Sexual Health Quarters, Health Consumers’ Council WA and the Centre for Women’s Safety and Wellbeing.

A graduate member of the Australian Institute of Company Directors, Rebecca is passionate about the importance of strong governance in the community services space.

Andrea Pizzie is the General Manager of Hepatitis Australia, having previously worked as the Lead Policy Analyst. Andrea has significant experience in health and social policy development, and specific experience in the development of national viral hepatitis policy and program design and costing.

Andrea has led successful budget submissions and has played key leadership roles in the development and delivery of national policy platforms.

Ashma Shrestha is the Lead Policy Analyst at Hepatitis Australia. She brings extensive experience in policy advocacy, strategic communications, and social and behaviour change programming across global health and within Australia.

Before joining Hepatitis Australia, Ashma worked with UN Women and UNICEF in South Asia, the Middle East, and Africa, as well as in the Australian non-profit sector.

Emily Skillin is the HepLink Program Manager at Hepatitis Australia, supporting delivery of the HepLink program in partnership with the eight state and territory community hepatitis organisations to strengthen the national community response to viral hepatitis.

She brings broad experience in health policy and program development, with a background in pharmaceutical policy, economic evaluations of medicines, medical research strategy, grant funding, and clinical trials.

Grace Hogan brings nearly seven years' experience working in hepatitis communications and partnerships, including delivery of major national initiatives such as World Hepatitis Day in Australia and The Juice campaign.

She has significant expertise in executing communications, social media strategy, event management, media and health literacy strategies.

Grace’s deep understanding of community research and engagement methods is bolstered by her qualifications in anthropology and sociology.

Outside of work you'll find her skiing or camping in one of Australia's many amazing national parks.

Grace is based in Canberra on Ngunnawal Country. 

Haylee Fox has a background as a health system, services and policy researcher, with work focused on maternal, sexual and reproductive health, and blood-borne viruses.

She has over a decade of experience in research and evaluation across academic and non-government settings.

Her work has centred on health equity and improving access to healthcare for priority populations.

Lived experience, opportunities for reflection and learning, roles in the community and public sectors, and the influence of key colleagues and leaders has helped John develop a strong sense of social justice and commitment to community. He works part-time at Hepatitis Australia in viral hepatitis policy.

Immediately prior to his tenure with Hepatitis Australia, John was Executive Officer at Hepatitis ACT from 2012 to 2018. Before that he held various government sector roles, including in alcohol and other drug policy and Aboriginal and Torres Strait Islander health policy.

When he’s not reading, talking or writing about viral hepatitis policy you might find him in his veggie patch, catching trout in the Snowy Mountains, or enjoying live music.

Liz is a Registered Nurse with almost 30 years of experience across hospitals, community health, and not-for-profit organisations. She have a strong background in infection prevention and control and is deeply committed to patient-centred care. She's passionate about education and empowerment, and supporting individuals and communities to make informed choices and feel confident in managing their healthcare needs.  

Rachael brings three decades of diverse experience across project management, community, and public health sectors to her role at Hepatitis Australia.

With qualifications in science, human resources and public health and over four years of specialized hepatitis experience, she is a driving force for health equity and community well-being. Known for her innovative solutions and commitment to quality outcomes, Rachael specializes in streamlining operations and driving continuous improvement within the organisation.

Outside of work, Rachael enjoys gardening and exploring the great outdoors with her family and friends.

Sara is an accomplished administrative and operations professional with extensive experience in supporting executive leadership and driving organisational excellence. 

Through her career she has demonstrated versatility across strategic support, human resources and practice management functions.  She thrives on streamlining operations, enhance team productivity and maintaining seamless coordination across all levels of the ogranisation.

Tuva is a communications professional with experience working in peak bodies and with a background working in IT and accessibility.